Cube Labs

🚀 𝐀𝐝𝐚𝐦𝐚𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐀𝐜𝐡𝐢𝐞𝐯𝐞𝐬 𝐚 𝐌𝐚𝐣𝐨𝐫 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 We are thrilled to announce that 𝐀𝐝𝐚𝐦𝐚𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡, a Cube Labs spin-off, has officially notified the Italian Ministry of Health about the registration of its second product, 𝐓𝐡𝐞𝐚𝐤𝐢𝐧𝐞® 𝐈𝐁𝐒-𝐂—an innovative #nutraceutical supplement designed to support gut health for individuals suffering from 𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐰𝐢𝐭𝐡 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧 (#IBS-C). Theakine® IBS-C is a dual-component supplement formulated with 𝐓𝐡𝐞𝐚𝐩𝐡𝐞𝐧𝐨𝐧 𝐄®, a 𝐩𝐚𝐭𝐞𝐧𝐭𝐞𝐝 𝐠𝐫𝐞𝐞𝐧 𝐭𝐞𝐚 𝐞𝐱𝐭𝐫𝐚𝐜𝐭, and a mix of 𝐩𝐫𝐨𝐛𝐢𝐨𝐭𝐢𝐜𝐬. This unique combination leverages the synergistic action of polyphenols and beneficial microorganisms to enhance gut health, reduce oxidative stress and inflammation, and improve the quality of life for IBS-C patients. 👉Read the full press release: https://lnkd.in/drrjSViA

We are thrilled to announce that our spin-off 𝐁𝐢𝐨 𝐀𝐮𝐫𝐮𝐦 has received authorization from the Italian Ministry of Health to launch a clinical study on 𝐍𝐞𝐮𝐫𝐞𝐭𝐢𝐧𝐚 𝐌𝐃—an innovative medical device designed to analyze #eye movements and detect early #neurodegenerative changes. The study, conducted in collaboration with Azienda Ospedaliero-Universitaria Careggi and the Università degli Studi di Firenze, marks a crucial step in advancing early diagnosis and monitoring of #cognitive decline through non-invasive eye-tracking technology.   🔬 𝐖𝐡𝐲 𝐝𝐨𝐞𝐬 𝐭𝐡𝐢𝐬 𝐦𝐚𝐭𝐭𝐞𝐫? The correlation between eye movements and brain health is a growing area of research. By precisely measuring ocular biomarkers, Neuretina MD could help identify early-stage #Alzheimer’s disease and other neurodegenerative conditions, paving the way for timely interventions. 👉 Check out our deep dive into this breakthrough on our website: https://lnkd.in/djchCGgp Huge congratulations to the Bio Aurum team for this achievement!

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 & 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: 𝐏𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞’𝐬 𝐅𝐮𝐭𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬🔬 How can innovation and research shape Europe’s global competitiveness? Today, at this exclusive event by Harvard Business School Online, industry leaders, entrepreneurs, and experts will explore the role of cutting-edge #research, #deeptech, and entrepreneurship in driving Europe’s future #growth. The event brings together industry leaders, entrepreneurs, and experts to discuss how scientific discovery and technological advancements are translating into real-world #impact. Among the speakers is Filippo Surace, Founder & CEO of Cube Labs, who will share his perspective on how deep tech and #LifeSciences innovation are fueling Europe's competitiveness in the global landscape. The discussion will be moderated by Dr. Ennio Tasciotti, a pioneer in biomimetic medicine and Founder of the Human Longevity Program at IRCCS San Raffaele. This event, initiated by Edoardo De Paolis, Founder of the Rome Chapter, and supported by team member Lucia Aliotta, represents a pivotal moment in the debate on how innovation and research can drive Europe’s future competitiveness. 👉𝐃𝐞𝐭𝐚𝐢𝐥𝐬 & 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧: https://lnkd.in/dUA6NkKg

We are growing! We are on the lookout for top talent to join our team at Cube Labs, where we transform cutting-edge science into life-changing ventures. If you're passionate about #innovation and eager to make an #impact in the #healthcare and life sciences ecosystem, this is your chance! We’re hiring: 📌 𝐉𝐮𝐧𝐢𝐨𝐫 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐫 – Rome Office; 📌 𝐆𝐫𝐚𝐧𝐭 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 – Maglie (LE) Office; 📌 𝐉𝐮𝐧𝐢𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 – Maglie (LE) Office. At Cube Labs, we don’t just support ventures—we build them, scale them, and empower them to shape the future of healthcare. If you’re ready to grow with us, check out the full job descriptions and apply today: 👉 https://lnkd.in/dYvAJrzd Know someone who'd be a great fit? Tag them in the comments!

🚀 We're back! Cube Labs is thrilled to announce the third edition of our 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐈𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐕𝐞𝐧𝐭𝐮𝐫𝐞𝐬 – a unique opportunity for entrepreneurs and innovators in #LifeSciences to turn their transformative ideas into successful #ventures. If you're passionate about revolutionizing #healthcare, biotech, or medtech and have a vision that can make a real-world #impact, this is your moment. We are looking for groundbreaking solutions that address critical needs, improve lives, and advance the #democratization of Life Sciences. ⏳Applications are open now, learn more here: https://lnkd.in/dQBngzTB

🎄✨ 𝐒𝐞𝐚𝐬𝐨𝐧'𝐬 𝐆𝐫𝐞𝐞𝐭𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 𝐂𝐮𝐛𝐞 𝐋𝐚𝐛𝐬! ✨🎄 This holiday season, we celebrate the power of #community, the spirit of #innovation, and the hope for a brighter future in healthcare and beyond. May this festive period be filled with joy, peace, and cherished moments with your loved ones. Let’s step into 2025 with renewed energy and a commitment to making a positive #impact together. Happy Holidays and a Prosperous New Year from all of us at Cube Labs!

🚀 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬: 𝐨𝐮𝐫 𝐩𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐢𝐬 𝐠𝐫𝐨𝐰𝐢𝐧𝐠! We are thrilled to announce the incorporation of two groundbreaking spin-offs into the Cube Labs portfolio: 𝐋𝐢𝐩𝐨𝐯𝐞𝐱𝐚 and 𝐅𝐥𝐮𝐨𝐃𝐞𝐭𝐞𝐜𝐭. These new ventures are poised to drive #innovation in the pharma and medtech industries. 𝐋𝐢𝐩𝐨𝐯𝐞𝐱𝐚 focuses on developing natural and synthetic molecules for #diabetes treatment, #obesity control, and liver health maintenance. Its applications range from nutraceuticals to pharmacological solutions. This spin-off is born from a collaboration with Prof. Marco Falasca and the Istituto Nazionale Biostrutture E Biosistemi (INBB). 𝐅𝐥𝐮𝐨𝐃𝐞𝐭𝐞𝐜𝐭 specializes in advanced technologies for detecting micro- and #nanoplastics. Using fluorogenic probes, FluoDetect identifies these particles in water, food, and potentially bodily fluids, addressing critical #environmental challenges. This innovative spin-off stems from the research of Prof. Luca Prodi and his team at the University of Bologna (Alma Mater Studiorum – Università di Bologna). Both ventures represent Cube Labs' commitment to transforming cutting-edge academic research into market-ready solutions, driving #impactful innovations in #healthcare and #sustainability.

Last night our founder and CEO, Filippo Surace, who was recognized last year in the Life Science category, had the honor to be selected by Forbes Italia to present the #2024CEOAward in the #Visionary category to Danila De Stefano, CEO of Unobravo. It was a memorable occasion dedicated to celebrating leaders whose strategic #vision and #innovation are driving the global competitiveness of Italian companies. Organized by Fiera Milano SpA, their knowledge unit, Business International Events, and Forbes Italia, this event is a key platform for exploring major trends and the future of business #leadership, while showcasing the excellence of #MadeinItaly. Congratulations to all the CEOs for their remarkable achievements, turning challenges into opportunities and leaving a lasting #impact on the global stage. ✨ Ph. credits: Forbes Italia

🌍𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐚𝐜𝐡: 𝐇𝐢𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐰𝐢𝐭𝐡 𝐁𝟒 At Cube Labs, we continue to push boundaries and unlock opportunities in destination markets through strategic partnerships. We're thrilled to announce that 𝐇𝐢𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, a Cube Labs portfolio company specializing in #AI solutions for healthcare, has signed a major commercial collaboration and licensing agreement with a strategic partner B4 S.r.l., a leader in #IoT and #IIoT technologies. This collaboration centers on a customized version of 𝐈𝐎𝐓𝐡𝐢𝐧𝐠, an innovative platform developed by B4, designed for #predictive #maintenance in #manufacturing settings, with application in pharma and medtech industrial plants. 📈 Together, we're setting the stage for growth in 𝐈𝐧𝐝𝐢𝐚 and the 𝐔𝐀𝐄, demonstrating the power of collaboration in driving #innovation globally. Discover more: https://lnkd.in/dxdQrqcn

📢 We’re proud to announce that 𝐓𝐡𝐞𝐚𝐤𝐢𝐧𝐞® 𝐏𝐫𝐨𝐬𝐭, a product of our portfolio company Adamas Biotech Srl, has been officially registered by Italy’s Ministry of Health! Developed with proprietary green tea catechins, Theaphenon E®, and backed by clinical studies led by Professor Saverio Bettuzzi, Theakine® Prost offers natural support for prostate health and relief from lower urinary tract symptoms (LUTS). This milestone paves the way for partnerships with strategic players in #urology to bring this breakthrough supplement to #market. 👉 Discover more: https://lnkd.in/d4CHjDG3